scholarly article | Q13442814 |
P356 | DOI | 10.1016/0092-8674(84)90188-0 |
P698 | PubMed publication ID | 6091915 |
P50 | author | Joseph L. Goldstein | Q271424 |
David W. Russell | Q37382061 | ||
P2093 | author name string | T Yamamoto | |
M S Brown | |||
W J Schneider | |||
C G Davis | |||
M L Casey | |||
P2860 | cites work | The LDL receptor locus in familial hypercholesterolemia: Multiple mutations disrupt transport and processing of a membrane receptor | Q24301258 |
Domain map of the LDL receptor: Sequence homology with the epidermal growth factor precursor | Q24301384 | ||
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity | Q26778490 | ||
57 Sequencing end-labeled DNA with base-specific chemical cleavages | Q27860479 | ||
A catalogue of splice junction sequences | Q27860696 | ||
2 New M13 vectors for cloning | Q27861042 | ||
Organization and expression of eucaryotic split genes coding for proteins | Q27861081 | ||
SV40-transformed simian cells support the replication of early SV40 mutants | Q28263905 | ||
The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin-like domains | Q28265873 | ||
Reconstituted low density lipoprotein: A vehicle for the delivery of hydrophobic fluorescent probes to cells | Q28322988 | ||
Coated pits, coated vesicles, and receptor-mediated endocytosis | Q28625700 | ||
The isolation and characterization of linked delta- and beta-globin genes from a cloned library of human DNA | Q29547602 | ||
A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells | Q29614815 | ||
Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells | Q29616544 | ||
Establishing homologies in protein sequences | Q29618225 | ||
High-Efficiency Cloning of Full-Length cDNA | Q29618285 | ||
Transformation of mammalian cells with genes from procaryotes and eucaryotes | Q34030262 | ||
Monensin interrupts the recycling of low density lipoprotein receptors in human fibroblasts | Q34252494 | ||
Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia | Q34253851 | ||
Recycling receptors: The round-trip itinerary of migrant membrane proteins | Q34254285 | ||
Computer-based characterization of epidermal growth factor precursor | Q34264382 | ||
5'-Terminal sequences of eucaryotic mRNA can be cloned with high efficiency | Q35710078 | ||
Use of antipeptide antibodies to demonstrate external orientation of the NH2-terminus of the low density lipoprotein receptor in the plasma membrane of fibroblasts | Q36208347 | ||
The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis | Q37605132 | ||
Genes of the major histocompatibility complex of the mouse | Q40097155 | ||
The Alu Family of Dispersed Repetitive Sequences | Q40129419 | ||
Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursor | Q40135209 | ||
Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins | Q40144506 | ||
A DNA sequence handling program | Q40492251 | ||
Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins | Q48397396 | ||
Base sequence studies of 300 nucleotide renatured repeated human DNA clones | Q48408328 | ||
Transcripts regulated during normal embryonic development and oncogenic transformation share a repetitive element. | Q52278682 | ||
Conversion of RNA to DNA in mammals: Alu-like elements and pseudogenes | Q59085304 | ||
19 Receptor-mediated endocytosis of low-density lipoprotein in cultured cells | Q70193016 | ||
Fluorescence Visualization of Receptor-Bound Low Density Lipoprotein in Human Fibroblasts | Q72912620 | ||
P4510 | describes a project that uses | SV-589 | Q54970925 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Low density lipoprotein receptor | Q425649 |
cell line | Q21014462 | ||
P304 | page(s) | 27-38 | |
P577 | publication date | 1984-11-01 | |
P1433 | published in | Cell | Q655814 |
P1476 | title | The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA | |
P478 | volume | 39 |
Q70174367 | "Pocket blotting": a method for transferring nucleic acids onto nylon membranes |
Q40419859 | (A-T)n tracts embedded in random sequence DNA--formation of a structure which is chemically reactive and torsionally deformable |
Q28261851 | 3,400 new expressed sequence tags identify diversity of transcripts in human brain |
Q24568257 | 39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein |
Q40944420 | 39-kDa receptor-associated protein (RAP) facilitates secretion and ligand binding of extracellular region of very-low-density-lipoprotein receptor: implications for a distinct pathway from low-density-lipoprotein receptor |
Q39027007 | 8-Bromoadenosine cyclic 3',5'-phosphate rapidly increases 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA in human granulosa cells: role of cellular sterol balance in controlling the response to tropic stimulation |
Q36713252 | A 19-kDa protein belonging to a new family is expressed in the Golgi apparatus of neural cells |
Q33197192 | A 2359-base pair DNA fragment from Cryptosporidium parvum encoding a repetitive oocyst protein |
Q34605035 | A Bayesian characterization of Hardy-Weinberg disequilibrium |
Q35296197 | A G protein-coupled receptor with low density lipoprotein-binding motifs suggests a role for lipoproteins in G-linked signal transduction |
Q71584520 | A G-1-to-A acceptor splice site LDLR mutant allele leads to reduced relative transcript levels in patients with heterozygous familial hypercholesterolemia |
Q40564584 | A RFLP associated with the low-density lipoprotein receptor gene (LDLR). |
Q28080618 | A century of cholesterol and coronaries: from plaques to genes to statins |
Q69861072 | A common DNA polymorphism of the low-density lipoprotein (LDL) receptor gene and its use in diagnosis |
Q54586415 | A deletion in the first cysteine-rich repeat of the low-density-lipoprotein receptor leads to the formation of multiple misfolded isomers. |
Q30812521 | A family of Arabidopsis plasma membrane receptors presenting animal beta-integrin domains. |
Q30423035 | A gene for a low density lipoprotein receptor-related protein in the nematode Caenorhabditis elegans |
Q61860999 | A gene/pseudogene tandem duplication encodes a cysteine-rich protein expressed during zygote development in Chlamydomonas reinhardtii |
Q73196786 | A high incidence of mutations in exon 6 of the low-density lipoprotein receptor gene in Greek familial hypercholesterolemia patients, including a novel mutation |
Q36791686 | A highly conserved mouse gene with a propensity to form pseudogenes in mammals |
Q28264354 | A human integrin beta 1 subunit with a unique cytoplasmic domain generated by alternative mRNA processing |
Q46959078 | A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins |
Q35196221 | A large deletion in the LDL receptor gene--the cause of familial hypercholesterolemia in three Italian families: a study that dates back to the 17th century (FH-Pavia) |
Q38321161 | A missense mutation in the low density lipoprotein receptor gene causes familial hypercholesterolemia in Sephardic Jews |
Q43556566 | A model for transposon-based eucaryote regulatory evolution |
Q42632060 | A new low density lipoprotein receptor homologue with 8 ligand binding repeats in brain of chicken and mouse |
Q41500632 | A new member with eleven binding repeats: novel insights into the LDL receptor gene family |
Q67992348 | A new polymorphism in exon 11 of the LDL receptor gene in healthy people and in familial hypercholesterolemia subjects |
Q72573399 | A new restriction-site polymorphism in exon 18 of the low density lipoprotein receptor (LDLR) gene |
Q73417826 | A novel V415A mutation in exon 9 of the low density lipoprotein receptor gene causing familial hypercholesterolemia |
Q43673991 | A novel approach to ex vivo gene therapy for familial hypercholesterolemia using human amniotic epithelial cells as a transgene carrier |
Q39720540 | A novel class of antihyperlipidemic agents with low density lipoprotein receptor up-regulation via the adaptor protein autosomal recessive hypercholesterolemia |
Q71999877 | A novel complex mutation in the LDL receptor gene probably caused by the simultaneous occurrence of deletion and insertion in the same region |
Q70484969 | A novel deletion in the low-density lipoprotein receptor gene in a patient with familial hypercholesterolemia from Petersburg |
Q71861783 | A novel deletion/inversion mutation in the low-density lipoprotein receptor gene as a cause of heterozygous familial hypercholesterolemia |
Q34122988 | A novel gene encoding a putative transmembrane protein with two extracellular CUB domains and a low-density lipoprotein class A module: isolation of alternatively spliced isoforms in retina and brain |
Q28140724 | A novel low-density lipoprotein receptor-related protein mediating cellular uptake of apolipoprotein E-enriched beta-VLDL in vitro |
Q28186647 | A novel mechanism for controlling the activity of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Multiple regulatory sites for 39-kDa receptor-associated protein |
Q74534110 | A novel member of the LDL receptor gene family with eleven binding repeats is structurally related to neural adhesion molecules and a yeast vacuolar protein sorting receptor |
Q73545144 | A novel mutation M-21V in exon 1 of the low density lipoprotein receptor gene causing familial hypercholesterolemia |
Q74449490 | A novel mutation in Exon 4 of the low density lipoprotein receptor gene resulting in heterozygous familial hypercholesterolemia associated with decreased ligand binding |
Q84035523 | A novel pathogenic variant of the LDLR gene in the Asian population and its clinical correlation with familial hypercholesterolemia |
Q73312053 | A novel point mutation (Pro84-->Ser) of the low density lipoprotein receptor gene in a family with moderate hypercholesterolemia |
Q33825087 | A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression. |
Q53629099 | A point mutation of low-density-lipoprotein receptor causing rapid degradation of the receptor. |
Q40506051 | A polymorphism in exon 2 of the human LDL-receptor gene (LDLR). |
Q48602812 | A possible role of carbohydrate moieties in prostaglandin D2 and prostaglandin E2 receptor proteins from the porcine temporal cortex |
Q44586822 | A proximal mouse chromosome 9 linkage map that further defines linkage groups homologous with segments of human chromosomes 11, 15, and 19 |
Q73105064 | A rapid method for detecting mutations of the human LDL receptor gene by complete cDNA sequencing |
Q71863214 | A rare silent G to T mutation in exon 4 of the human low density lipoprotein receptor gene |
Q29616158 | A receptor-mediated pathway for cholesterol homeostasis |
Q44409232 | A sensitive RNase protection assay for the quantitation of the mRNAs for the LDL receptor and HMG-CoA reductase in human total RNA Effects of treatments on cells in culture designed to up- and down-regulate expression of the LDL receptor |
Q70047512 | A single receptor binds both insulin-like growth factor II and mannose-6-phosphate |
Q33593165 | A study of familial hypercholesterolaemia in Iceland using RFLPs |
Q24540252 | A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32 |
Q44742662 | A two-module region of the low-density lipoprotein receptor sufficient for formation of complexes with apolipoprotein E ligands |
Q35798990 | AHaelIIpolymorphism in the 3′ untranslated region of the low density lipoprotein receptor (LDLR) gene |
Q36552698 | Accelerated atheroma in the antiphospholipid syndrome |
Q34180927 | Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region |
Q41197387 | Activation of acyl-coenzyme A:cholesterol acyltransferase activity by cholesterol is not due to altered mRNA levels in HepG2 cells |
Q51745214 | Activity-associated effect of LDL receptor missense variants located in the cysteine-rich repeats. |
Q38349003 | Additive and independent responses in a single receptor: aspartate and maltose stimuli on the tar protein |
Q64382637 | Adenoviral delivery of low-density lipoprotein receptors to hyperlipidemic rabbits: receptor expression modulates high-density lipoproteins |
Q36201407 | Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice |
Q46195529 | All Three LDL Receptor Homology Regions of the LDL Receptor-Related Protein Bind Multiple Ligands |
Q48368062 | Alternative 5' exons in c-abl mRNA. |
Q69522386 | Alu sequences in the LDL receptor messenger RNA |
Q40472693 | Alu sequences transcription in X. laevis oocytes: nuclear-cytoplasmic partitioning and evidence for 3' end processing reactions |
Q36312269 | American Gastroenterological Association future trends committee report: the application of genomic and proteomic technologies to digestive disease diagnosis and treatment and their likely impact on gastroenterology clinical practice |
Q41761661 | Amino acid distributions around O-linked glycosylation sites |
Q36221099 | Amino acid sequence and domain structure of entactin. Homology with epidermal growth factor precursor and low density lipoprotein receptor |
Q33557514 | Amino acid sequence of mouse nidogen, a multidomain basement membrane protein with binding activity for laminin, collagen IV and cells |
Q41363012 | Amino acid sequence of rabbit kidney neutral endopeptidase 24.11 (enkephalinase) deduced from a complementary DNA. |
Q44902213 | Amino acids bracketing the predicted transmembrane domains of membrane proteins |
Q70921280 | Amino-terminal region of the beta-amyloid precursor protein activates mitogen-activated protein kinase |
Q42539427 | Amiodarone decreases gene expression of low-density lipoprotein receptor at both the mRNA and the protein level |
Q42285067 | Amiodarone-induced hypercholesterolemia is associated with a decrease in liver LDL receptor mRNA. |
Q52642763 | An ESR study of the effect of an electrostatic field on binding of divalent cations to the surface of serum low-density lipoproteins. |
Q71347571 | An Iranian-Armenian LDLR frameshift mutation causing familial hypercholesterolemia |
Q72407538 | An alanine29-serine variant in exon 2 of the low density lipoprotein receptor gene: no association with hypercholesterolemia |
Q68256929 | An antibody to the low-density lipoprotein (LDL) receptor that partially inhibits the binding of LDL to cultured human fibroblasts |
Q41521241 | An antiviral soluble form of the LDL receptor induced by interferon |
Q71958925 | An efficient screening procedure detecting six novel mutations in the LDL receptor gene in Swedish children with hypercholesterolemia |
Q33597678 | An exon 4 mutation identified in the majority of South African familial hypercholesterolaemics |
Q35194489 | An informative panel of somatic cell hybrids for physical mapping on human chromosome 19q |
Q39464471 | An overview of the human interleukin-2 receptor: molecular, biochemical, and functional properties |
Q48070730 | An unusual mosaic protein with a protease domain, encoded by the nudeI gene, is involved in defining embryonic dorsoventral polarity in Drosophila |
Q40257542 | Analysis of alternatively spliced isoforms of human LDL receptor mRNA. |
Q30452625 | Analysis of the subgroup A avian sarcoma and leukosis virus receptor: the 40-residue, cysteine-rich, low-density lipoprotein receptor repeat motif of Tva is sufficient to mediate viral entry. |
Q36587959 | Ancient ubiquitous protein-1 mediates sterol-induced ubiquitination of 3-hydroxy-3-methylglutaryl CoA reductase in lipid droplet-associated endoplasmic reticulum membranes |
Q42259093 | Ankyrin-binding proteins related to nervous system cell adhesion molecules: candidates to provide transmembrane and intercellular connections in adult brain |
Q38182083 | Antibodies to the insulin receptor as tools in the study of receptor structure and function |
Q41966472 | Antipeptide antibody against the human low-density-lipoprotein receptor. Characterization and cross-reactivity with bovine lymphocytes |
Q37318783 | Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome |
Q34640735 | Apolipoprotein B metabolism: tracer kinetics, models, and metabolic studies |
Q38348455 | Apolipoprotein B: structure, biosynthesis and role in the lipoprotein assembly process |
Q46470856 | Apolipoprotein E expression by human-monocyte-derived macrophages. Modulation by opsonised zymosan and cholesterol |
Q69993632 | Apolipoprotein E is the determinant that mediates the receptor uptake of beta-very low density lipoproteins by mouse macrophages |
Q35577335 | Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia |
Q28294791 | Apolipoprotein E: cholesterol transport protein with expanding role in cell biology |
Q40737965 | Apolipoprotein E: structure-function relationships |
Q71637238 | Application of long polymerase chain reaction in the study of the LDL receptor gene |
Q39312993 | Application of molecular techniques to the study of human physiological variation |
Q74291830 | Association between LDLR polymorphism and diseases in the Japanese population: aging and distribution of the polymorphism |
Q28564763 | Association of the low-density lipoprotein receptor with caveolae in hamster and rat liver |
Q93612468 | Atherogenic lipoproteins and coronary artery disease: concepts derived from recent advances in cellular and molecular biology |
Q33690937 | Atherogenic lipoproteins and tyrosine kinase mitogenic signaling in mesangial cells. |
Q37378106 | Atherosclerosis in autoimmune diseases |
Q52852275 | Atherosclerosis in primary antiphospholipid syndrome. |
Q24339583 | Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor |
Q37283009 | Autoimmune-mediated atherothrombosis |
Q36634114 | Autosomal dominant hypercholesterolemia: needs for early diagnosis and cascade screening in the tunisian population |
Q38345498 | Avian and murine LR8B and human apolipoprotein E receptor 2: differentially spliced products from corresponding genes. |
Q40848761 | Axonal glycoproteins with immunoglobulin- and fibronectin type III-related domains in vertebrates: structural features, binding activities, and signal transduction |
Q34302993 | Azalanstat (RS-21607), a lanosterol 14α-demethylase inhibitor with cholesterol-lowering activity |
Q73642829 | Backbone dynamics of a module pair from the ligand-binding domain of the LDL receptor |
Q34552498 | Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins |
Q36136767 | Bile acid biosynthesis |
Q28304050 | Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide |
Q24303660 | Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation |
Q68799073 | Biochemical characterization of the 9.3 antigens of human T-cells: simultaneous expression of disulfide-bonded 90-kilodalton dimers and free subunits at the cell surface |
Q34608575 | Biochemical defects of mutant nudel alleles causing early developmental arrest or dorsalization of the Drosophila embryo |
Q38595898 | Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: an update |
Q35200777 | Blood purification therapies using dextran sulfate cellulose columns Liposorber and Selesorb |
Q90631916 | Bone morphogenetic protein 1 cleaves the linker region between ligand-binding repeats 4 and 5 of the LDL receptor and makes the LDL receptor non-functional |
Q89620056 | CRISPR/Cas9-Mediated Vitellogenin Receptor Knockout Leads to Functional Deficiency in the Reproductive Development of Plutella xylostella |
Q39615123 | Calcium as a crucial cofactor for low density lipoprotein receptor folding in the endoplasmic reticulum |
Q41970963 | Calcium binding to tandem repeats of EGF-like modules. Expression and characterization of the EGF-like modules of human Notch-1 implicated in receptor-ligand interactions |
Q42858494 | Calmodulin antagonists increase the amount of mRNA for the low-density-lipoprotein receptor in skin fibroblasts |
Q28575423 | Calnuc binds to LRP9 and affects its endosomal sorting |
Q69370209 | Candidate gene approach to type IIa hypercholesterolaemia |
Q34192970 | Cassette of eight exons shared by genes for LDL receptor and EGF precursor |
Q38138939 | Causes of high blood cholesterol |
Q29347262 | Cavin-3 dictates the balance between ERK and Akt signaling |
Q70156358 | Cell-surface receptors: puzzles and paradigms |
Q28304364 | Cellular internalization and degradation of thrombospondin-1 is mediated by the amino-terminal heparin binding domain (HBD). High affinity interaction of dimeric HBD with the low density lipoprotein receptor-related protein |
Q24306525 | Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily |
Q24635869 | Characteristics of a multicopy gene family predominantly consisting of processed pseudogenes |
Q68433428 | Characteristics of chylomicron remnant uptake into rat liver |
Q36223604 | Characteristics of the tyrosine recognition signal for internalization of transmembrane surface glycoproteins. |
Q42083328 | Characterization and isolation of a high-density-lipoprotein-binding protein from bovine corpus luteum plasma membrane |
Q28243841 | Characterization and sequence of an additional 15-lipoxygenase transcript and of the human gene |
Q36723150 | Characterization of a cDNA encoding a cysteine-rich cell surface protein located in the flagellar pocket of the protozoan Trypanosoma brucei |
Q50557392 | Characterization of a disease-causing Glu119-Lys mutation in the low-density lipoprotein receptor gene in two Danish families with heterozygous familial hypercholesterolemia. |
Q36896711 | Characterization of a family of gamma-ray-induced CHO mutants demonstrates that the ldlA locus is diploid and encodes the low-density lipoprotein receptor |
Q33207709 | Characterization of a major member of the rat pregnancy-specific glycoprotein family |
Q51763927 | Characterization of a naturally occurring degradation product of the LDL receptor. |
Q41030697 | Characterization of a novel liver-specific protein/DNA binding site in the human HMG CoA reductase promoter |
Q28292232 | Characterization of cDNA encoding human pregnancy-specific beta 1-glycoprotein from placenta and extraplacental tissues and their comparison with carcinoembryonic antigen |
Q43911134 | Characterization of genes with a putative key role in the parasitic lifestyle of the nematode Strongyloides ratti |
Q28272238 | Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis |
Q73503578 | Characterization of prolactin- and growth hormone-binding proteins in milk and their diversity among species |
Q44571036 | Characterization of residues in the cytoplasmic domain of the LDL receptor required for exit from the endoplasmic reticulum |
Q35246204 | Characterization of six partial deletions in the low-density-lipoprotein (LDL) receptor gene causing familial hypercholesterolemia (FH) |
Q28576279 | Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes--a molecule related to nerve growth factor receptor |
Q70321922 | Characterization of the human interleukin 2 receptor at the DNA, RNA, and protein level |
Q58868055 | Characterization of the rat LDL receptor 5′-flanking region |
Q61897315 | Characterization of three mutations of the low density lipoprotein receptor gene in Italian patients with familial hypercholesterolemia |
Q30703351 | Characterization of uterine epidermal growth factor during early pregnancy in pigs |
Q33953583 | Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. |
Q37638077 | Chicken oocyte growth is mediated by an eight ligand binding repeat member of the LDL receptor family |
Q48066419 | Chiloscyllium plagiosum low-density lipoprotein receptor: evolutionary conservation of five different functional domains |
Q45081451 | Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs |
Q28609699 | Cholesterol biosynthesis and metabolism |
Q24652984 | Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL |
Q33417684 | Cholesterol-dependent anaplasma phagocytophilum exploits the low-density lipoprotein uptake pathway |
Q36355194 | Cholesterol: its regulation and role in central nervous system disorders |
Q36216333 | Chromosomal localization of glutamate receptor genes: relationship to familial amyotrophic lateral sclerosis and other neurological disorders of mice and humans |
Q34424993 | Cleavage site for sterol-regulated protease localized to a leu-Ser bond in the lumenal loop of sterol regulatory element-binding protein-2. |
Q71621598 | Clinically applicable mutation screening in familial hypercholesterolemia |
Q44680098 | Cloning and Expression of Human Insulin-Like Growth Factor Binding Protein 3 |
Q43654208 | Cloning and characterization of bovine insulin-like growth factor binding protein-3 (bIGFBP-3) |
Q24319172 | Cloning and expression analysis of a novel human serine hydrolase with sequence similarity to prokaryotic enzymes involved in the degradation of aromatic compounds |
Q41311793 | Cloning and expression of human tissue factor cDNA. |
Q36478935 | Cloning and expression of multiple protein kinase C cDNAs |
Q34337688 | Cloning and expression of recombinant, functional ricin B chain |
Q48325833 | Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family |
Q48079203 | Cloning and nucleotide sequence of cDNA encoding Asp-hemolysin from Aspergillus fumigatus |
Q28568754 | Cloning and regulation of cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis |
Q48167223 | Cloning and sequencing of the rat preproepidermal growth factor cDNA: comparison with mouse and human sequences |
Q48050460 | Cloning and subcellular location of an Arabidopsis receptor-like protein that shares common features with protein-sorting receptors of eukaryotic cells |
Q44470603 | Cloning of Alu-containing cDNAs from human fibroblasts and identification of small Alu+ poly(A)+ RNAs in a variety of human normal and tumor cells |
Q42805194 | Cloning of a cDNA encoding a putative human very low density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9pter-p23. |
Q24634230 | Cloning of cDNA encoding steroid 11 beta-hydroxylase (P450c11) |
Q24610825 | Cloning of the human estrogen receptor cDNA |
Q35028843 | Cloning of the human glucocorticoid receptor cDNA |
Q68961308 | Cloning of the human oestrogen receptor cDNA |
Q33846190 | Cloning of the mRNA for the protein that crosslinks to the egg peptide speract |
Q34332370 | Cloning, expression, and pore-forming properties of mature and precursor forms of pleurotolysin, a sphingomyelin-specific two-component cytolysin from the edible mushroom Pleurotus ostreatus |
Q28239399 | Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2) |
Q46928641 | Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk |
Q54708790 | Common Mutations in the Low-Density-Lipoprotein–Receptor Gene Causing Familial Hypercholesterolemia in the Japanese Population |
Q34247066 | Common low-density lipoprotein receptor mutations in the French Canadian population |
Q42471086 | Comparison of expression and regulation of the high-density lipoprotein receptor SR-BI and the low-density lipoprotein receptor in human adrenocortical carcinoma NCI-H295 cells |
Q44779178 | Competitive ion binding to low density lipoproteins: an electron spin resonance study |
Q40796156 | Complement factor I and cofactors in control of complement system convertase enzymes |
Q34048315 | Complete amino acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA. |
Q35809266 | Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family |
Q38293925 | Complexity of molecular genetics of dyslipidemia in a family highly susceptible to ischemic heart disease |
Q30357459 | Computational diagnosis of protein conformational diseases: short molecular dynamics simulations reveal a fast unfolding of r-LDL mutants that cause familial hypercholesterolemia. |
Q67536181 | Computer prediction of antigenic and topogenic domains in HSV-1 and HSV-2 glycoprotein B (gB) |
Q68463468 | Conformational analysis of lipid-associating proteins in a lipid environment |
Q43925536 | Conservation of the modular structure of complement factor I through vertebrate evolution |
Q48275636 | Conserved sequences flank variable tandem repeats in two alleles of the G surface protein of Paramecium primaurelia |
Q33850217 | Constitutive endocytosis of HLA class I antigens requires a specific portion of the intracytoplasmic tail that shares structural features with other endocytosed molecules |
Q77787835 | Construction and in vitro functional evaluation of a low-density lipoprotein receptor/transferrin fusion protein as a therapeutic tool for familial hypercholesterolemia |
Q36198591 | Conversion of a human low-density lipoprotein receptor ligandbinding repeat to a virus receptor: identification of residues important for ligand specificity |
Q45114944 | Cooperation between fixed and low pH-inducible interfaces controls lipoprotein release by the LDL receptor |
Q33582226 | Correction of the genetic defect in hepatocytes from the Watanabe heritable hyperlipidemic rabbit. |
Q28287140 | Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 A resolution |
Q41172492 | Cyclosporine inhibits catabolism of low-density lipoproteins in HepG2 cells by about 25%. |
Q36531225 | Cytoplasmic sequence required for basolateral targeting of LDL receptor in livers of transgenic mice |
Q70358364 | DNA polymorphisms of apolipoprotein A-I/C-III and insulin genes in familial hypertriglyceridemia and coronary heart disease |
Q44137040 | DNA sequence polymorphisms in Alu repeats |
Q40997597 | DNA technology in forensic applications |
Q36918033 | DNA-mediated transfer of a human gene required for low-density lipoprotein receptor expression and for multiple Golgi processing pathways |
Q41595233 | Decreased low-density lipoprotein receptor function and mRNA levels in lymphocytes from uremic patients |
Q24629015 | Defective forebrain development in mice lacking gp330/megalin |
Q34162054 | Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit |
Q72551425 | Deletion of exon 15 of the LDL receptor gene is associated with a mild form of familial hypercholesterolemia. FH-Espoo |
Q38334044 | Deletion of two growth-factor repeats from the low-density-lipoprotein receptor accelerates its degradation |
Q50190415 | Deoxycholic acid treatment in patients with cholesterol gallstones: failure to detect a suppression of cholesterol 7alpha-hydroxylase activity |
Q71183992 | Desialylated LDL uptake in human and mouse macrophages can be mediated by a lectin receptor |
Q56969896 | Detection and Analysis of Interferon-α Receptors on Plasma Membranes and in Detergent Extracts |
Q53845991 | Detection of a frequent polymorphism in exon 10 of the low-density lipoprotein receptor gene |
Q50556731 | Detection of a single base deletion in codon 424 of the low density lipoprotein receptor gene in a Danish family with familial hypercholesterolemia. |
Q35798874 | Detection of four new Taql alleles with probe St14-1 |
Q43032140 | Detection of mutations and large rearrangements of the low-density lipoprotein receptor gene in Taiwanese patients with familial hypercholesterolemia |
Q35833160 | Detection of two forms of GP330. Their role in Heymann nephritis. |
Q64448395 | Development of human chromosome-specific PCR primers for characterization of somatic cell hybrids |
Q71646979 | Development of selective low-density lipoprotein (LDL) apheresis system: immobilized polyanion as LDL-specific adsorption for LDL apheresis system |
Q50243986 | Development of selective low-density lipoprotein (LDL) apheresis system: immobilized polyanion as LDL-specific adsorption for LDL apheresis system. 1996. |
Q42632319 | Developmental expression and characterization of the gene encoding spore coat protein SP60 in Dictyostelium discoideum |
Q36919709 | Developmental regulation of a novel repetitive protein of Trypanosoma brucei |
Q69919503 | Diagnosis of familial hypercholesterolaemia using DNA probes for the low-density lipoprotein (LDL) receptor gene |
Q34150907 | Dietary cholesterol and downregulation of cholesterol 7 alpha-hydroxylase and cholesterol absorption in African green monkeys |
Q41710035 | Dietary fatty acids and the regulation of plasma low density lipoprotein cholesterol concentrations |
Q42280270 | Different molecular forms of rat kidney gp330, the dominant autoantigen of active Heymann nephritis |
Q57337263 | Differential effect of dietary fat saturation and cholesterol on hepatic apolipoprotein gene expression in rats |
Q28577205 | Differential expression of LR11 during proliferation and differentiation of cultured neuroblastoma cells |
Q28209002 | Differential functions of members of the low density lipoprotein receptor family suggested by their distinct endocytosis rates |
Q38346722 | Differential functions of triplicated repeats suggest two independent roles for the receptor-associated protein as a molecular chaperone |
Q28188278 | Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase |
Q67697823 | Differentiation of lipid-associating helices by use of three-dimensional molecular hydrophobicity potential calculations |
Q39307795 | Digital imaging fluorescence microscopy |
Q54566097 | Disorders of cholesterol metabolism and their unanticipated convergent mechanisms of disease. |
Q38348028 | Dissection of the domain architecture of the alpha2macroglobulin-receptor-associated protein |
Q34537634 | Diverse roles for the LDL receptor family |
Q85958186 | Docosahexanoic acid modifies low-density lipoprotein receptor abundance in HepG2 cells via suppression of the LXRα-Idol pathway |
Q46076317 | Donor origin of a posttransplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping |
Q73186590 | Doubling expression of the low density lipoprotein receptor by truncation of the 3'-untranslated region sequence ameliorates type iii hyperlipoproteinemia in mice expressing the human apoe2 isoform |
Q33631359 | Down-regulation of beta-adrenergic receptors: agonist-induced reduction in receptor mRNA levels |
Q45173451 | Down-regulation of hepatic LDL receptor expression in experimental nephrosis |
Q36473616 | Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1. |
Q34191561 | Duplication of seven exons in LDL receptor gene caused by Alu-Alu recombination in a subject with familial hypercholesterolemia |
Q36672095 | Dutch Caucasian population data on the loci LDLR, GYPA, HBGG, D7S8, and GC. |
Q52191311 | Early diet influences hepatic hydroxymethyl glutaryl coenzyme A reductase and 7alpha-hydroxylase mRNA but not low-density lipoprotein receptor mRNA during development. |
Q72431180 | Effect of dietary cholesterol on activity and mRNA levels of hepatic lipase in rat |
Q42988950 | Effect of reduced low-density lipoprotein receptor level on HepG2 cell cholesterol metabolism |
Q73912335 | Effect of short interspersed element sequences on the integration and expression of a reporter gene in the preimplantation-stage mouse embryos |
Q68366770 | Effect of thyroid hormone on hepatic cholesterol 7 alpha hydroxylase, LDL receptor, HMG-CoA reductase, farnesyl pyrophosphate synthetase and apolipoprotein A-I mRNA levels in hypophysectomized rats |
Q45877135 | Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene |
Q47815012 | Effects of a 9.6-kb deletion of the LDL receptor gene (FH Helsinki) on structure and levels of mRNA. |
Q44086566 | Effects of combined treatment with pravastatin and ursodeoxycholic acid on hepatic cholesterol metabolism. |
Q43183076 | Effects of pravastatin on cholesterol metabolism of cholesterol-fed heterozygous WHHL rabbits |
Q68021722 | Effects of pravastatin sodium alone and in combination with cholestyramine on hepatic, intestinal and adrenal low density lipoprotein receptors in homozygous Watanabe heritable hyperlipidemic rabbits |
Q73167110 | Effects of reduced maternal lipoprotein-cholesterol availability on placental progesterone biosynthesis in the baboon |
Q33645475 | Efficient expression of retroviral vector-transduced human low density lipoprotein (LDL) receptor in LDL receptor-deficient rabbit fibroblasts in vitro |
Q39631068 | Efficient nuclear drug translocation and improved drug efficacy mediated by acidity-responsive boronate-linked dextran/cholesterol nanoassembly |
Q64378146 | Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency |
Q34492205 | Emphysema, cirrhosis, and heart block in a young patient with partial alpha 1 antitrypsin deficiency (PiMZ phenotype). |
Q45858453 | Enhanced plasma cholesterol lowering effect of retrovirus-mediated LDL receptor gene transfer to WHHL rabbit liver after improved surgical technique and stimulation of hepatocyte proliferation by combined partial liver resection and thymidine kinase |
Q41032564 | Entactin-2: a new member of basement membrane protein with high homology to entactin/nidogen |
Q34157138 | Entactin: structure and function |
Q39595533 | Epidermal growth factor and its receptor |
Q69864674 | Epidermal growth factor. Is the precursor a receptor? |
Q34382813 | Estimating minimum allele frequencies for DNA profile frequency estimates for PCR-based loci |
Q71479743 | Evaluation and usefulness of reverse dot blot DNA-PolyMarker typing in forensic case work |
Q77125463 | Evaluation of a clinically applicable mutation screening technique for genetic diagnosis of familial hypercholesterolemia and familial defective apolipoprotein B |
Q33848680 | Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors |
Q57685705 | Evidence for similar function of transmembrane segments in receptor and membrane-anchored proteins |
Q41661872 | Evidence for sterol-independent regulation of low-density lipoprotein receptor activity in Hep-G2 cells |
Q73550000 | Evidence of macrophage foam cell formation by very low-density lipoprotein receptor: interferon-gamma inhibition of very low-density lipoprotein receptor expression and foam cell formation in macrophages |
Q45016220 | Evidence that density-dependent growth arrest is a two-stage process in WI-38 cells |
Q24531838 | Evolutionary conserved close linkage of the c-fes/fps proto-oncogene and genetic sequences encoding a receptor-like protein |
Q35607500 | Exon-Alu recombination deletes 5 kilobases from the low density lipoprotein receptor gene, producing a null phenotype in familial hypercholesterolemia |
Q28306508 | Exon/intron organization, chromosome localization, alternative splicing, and transcription units of the human apolipoprotein E receptor 2 gene |
Q38601708 | Exploring the complete mutational space of the LDL receptor LA5 domain using molecular dynamics: linking SNPs with disease phenotypes in familial hypercholesterolemia |
Q38305764 | Expression and folding of human very-low-density lipoprotein receptor fragments: neutralization capacity toward human rhinovirus HRV2. |
Q36271262 | Expression and regulation of apolipoprotein E receptors in the cells of the central nervous system in culture: A review |
Q24295226 | Expression and structure of the human NGF receptor |
Q24312598 | Expression cloning of a novel scavenger receptor from human endothelial cells |
Q34143741 | Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions |
Q33918423 | Expression of an LDL receptor allele with two different mutations (E256K and I402T). |
Q44895405 | Expression of growth regulatory genes in primary human testicular neoplasms |
Q37480208 | Expression of human epidermal growth factor precursor cDNA in transfected mouse NIH 3T3 cells |
Q73630854 | Expression of very low density lipoprotein receptor mRNA in circulating human monocytes: its up-regulation by hypoxia |
Q34560107 | Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine |
Q72294570 | FH Afrikaner-3 LDL receptor mutation results in defective LDL receptors and causes a mild form of familial hypercholesterolemia |
Q72569923 | FH-Sydney 1 and 2: two novel frameshift mutations in exon 10 of the low-density lipoprotein receptor gene detected by heteroduplex formation |
Q104736146 | Familial Hypercholesterolemia in Russia: Three Decades of Genetic Studies |
Q34048881 | Familial hypercholesterolaemia as an example of early diagnosis of coronary artery disease risk by DNA techniques |
Q72138652 | Familial hypercholesterolaemia caused by a non-sense mutation in codon 329 of the LDL receptor gene |
Q36275435 | Familial hypercholesterolemia and response to statin therapy according to LDLR genetic background |
Q43530662 | Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype. |
Q38985197 | Familial hypercholesterolemia in Morocco: first report of mutations in the LDL receptor gene. |
Q53875569 | Familial hypercholesterolemia in South African Afrikaners. PvuII and StuI DNA polymorphisms in the LDL-receptor gene consistent with a predominating founder gene effect. |
Q24797382 | Familial hypercholesterolemia in St-Petersburg: the known and novel mutations found in the low density lipoprotein receptor gene in Russia |
Q37741876 | Familial hypercholesterolemia in a rhesus monkey pedigree: molecular basis of low density lipoprotein receptor deficiency |
Q35076982 | Familial hypercholesterolemia mutations in Petrozavodsk: no similarity to St. Petersburg mutation spectrum |
Q57818471 | Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice |
Q28584207 | Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat |
Q33848081 | Finnish type of low density lipoprotein receptor gene mutation (FH-Helsinki) deletes exons encoding the carboxy-terminal part of the receptor and creates an internalization-defective phenotype |
Q28647131 | Flux analysis of cholesterol biosynthesis in vivo reveals multiple tissue and cell-type specific pathways |
Q89063747 | FlyXCDB-A Resource for Drosophila Cell Surface and Secreted Proteins and Their Extracellular Domains |
Q37698136 | Focal accumulation of an apolipoprotein B-based synthetic oligopeptide in the healing rabbit arterial wall |
Q34382612 | Folate receptors targeted to clathrin-coated pits cannot regulate vitamin uptake |
Q30752588 | Folding determinants of LDL receptor type A modules |
Q45041602 | Founder mutations in the LDL receptor gene contribute significantly to the familial hypercholesterolemia phenotype in the indigenous South African population of mixed ancestry |
Q33681907 | Four DNA polymorphisms in the LDL receptor gene: their genetic relationship and use in the study of variation at the LDL receptor locus. |
Q72912457 | Four new nucleotide sequence polymorphisms in the LDL receptor gene detected by SSCP analysis |
Q72235635 | Four novel partial deletions of LDL-receptor gene in Italian patients with familial hypercholesterolemia |
Q71840901 | Frequencies of the 5 PCR-based genetic markers LDLR, GYPA, HBGG, D7S8, and GC in a north Bavarian population |
Q73177369 | Frequencies of the five PCR-based genetic markers LDLR, GYPA, HBGG, D7S8 and GC in the population of Asturias (North Spain) |
Q54601045 | Frequencies of variants of candidate genes in different age groups of hypertensives. |
Q35205250 | From diet to DNA: dietary patterning of gene expression |
Q70156049 | Functional adaptations of transbilayer proteins |
Q39503662 | Functional and structural characteristics of EGF and its receptor and their relationship to transforming proteins |
Q51746086 | Functional characterization and classification of frequent low-density lipoprotein receptor variants. |
Q41382412 | Functional expression of human and mouse low density lipoprotein receptors in hybridomas |
Q68786274 | Further mapping of markers around the centromere of human chromosome 19 |
Q69808725 | Gene analysis and its role in predicting susceptibility to disease |
Q36566264 | Gene conversion as a secondary mechanism of short interspersed element (SINE) evolution |
Q34181152 | Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts |
Q33672301 | Gene mapping and chromosome 19. |
Q28288106 | Gene transfer and molecular cloning of the rat nerve growth factor receptor |
Q68164578 | Gene-gene interaction between the low density lipoprotein receptor and apolipoprotein E loci affects lipid levels |
Q38982764 | Genetic Association of the Porcine C9 Complement Component with Hemolytic Complement Activity |
Q52564391 | Genetic analysis in a compound heterozygote family with familial hypercholesterolemia. |
Q42521671 | Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism |
Q72611387 | Genetic diagnosis with the denaturing gradient gel electrophoresis technique improves diagnostic precision in familial hypercholesterolemia |
Q46824962 | Genetic heterogeneity of autosomal dominant hypercholesterolemia in Mexico |
Q40855553 | Genetic mutations affecting human lipoproteins, their receptors, and their enzymes. |
Q69371093 | Genetic polymorphism of the apolipoprotein B gene locus influences serum LDL cholesterol level in familial hypercholesterolemia |
Q39764306 | Genetic polymorphisms related to glucose and triglyceride intolerance |
Q41108660 | Genetic structure and organization of the membrane attack complement components |
Q37172163 | Genetic variation and atherosclerosis |
Q40299838 | Genomewide association study on chronic periodontitis in Korean population: results from the Yangpyeong health cohort. |
Q36011632 | Genomic DNA with transformation-related activity and melanoma antigen expression |
Q37422864 | George Lyman Duff Memorial Lecture. Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease |
Q37033150 | Geranylgeranyl-regulated transport of the prenyltransferase UBIAD1 between membranes of the ER and Golgi |
Q41528680 | Giant lens, a gene involved in cell determination and axon guidance in the visual system of Drosophila melanogaster |
Q50200558 | Global flexibility in a sensory receptor: a site-directed cross-linking approach |
Q24324257 | Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase |
Q43816776 | HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells |
Q37740339 | Half a Century Tales of Familial Hypercholesterolemia (FH) in Japan |
Q84129312 | Haplotype analyses, mechanism and evolution of common double mutants in the human LDL receptor gene |
Q72660528 | Haplotype analysis at the low density lipoprotein receptor locus in normal and familial hypercholesterolemia Norwegian subjects |
Q33676491 | Haplotype associations of three DNA polymorphisms at the human low density lipoprotein receptor gene locus in familial hypercholesterolaemia |
Q33598443 | Haplotypes identified by 10 DNA restriction fragment length polymorphisms at the human low density lipoprotein receptor gene locus |
Q35892552 | Hc-daf-2 encodes an insulin-like receptor kinase in the barber's pole worm, Haemonchus contortus, and restores partial dauer regulation |
Q24322087 | Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor |
Q36214767 | Heterologous transmembrane and cytoplasmic domains direct functional chimeric influenza virus hemagglutinins into the endocytic pathway |
Q41644499 | High frequency of the Lebanese allele of the LDLr gene among Brazilian patients with familial hypercholesterolaemia |
Q33750064 | Higher incidence of mild cognitive impairment in familial hypercholesterolemia |
Q43959430 | Homozygous familial hypercholesterolemia in Lebanon: a genotype/phenotype correlation |
Q47330918 | How multi-scale structural biology elucidated context-dependent variability in ectodomain conformation along with the ligand capture and release cycle for LDLR family members. |
Q69804954 | Human ApoB-100 gene resides in the p23----pter region of chromosome 2 |
Q30403358 | Human apolipoprotein B: structure of carboxyl-terminal domains, sites of gene expression, and chromosomal localization |
Q24309556 | Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain |
Q24629937 | Human cytochrome P-450 4 mRNA and gene: part of a multigene family that contains Alu sequences in its mRNA |
Q28115244 | Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization |
Q24610589 | Human genes involved in cholesterol metabolism: chromosomal mapping of the loci for the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-coenzyme A reductase with cDNA probes |
Q28615460 | Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes |
Q70374923 | Human interleukin 2 receptor (Tac antigen) |
Q68368985 | Human low density lipoprotein receptor expressed in Xenopus oocytes. Conserved signals for O-linked glycosylation and receptor-mediated endocytosis |
Q46266191 | Human low density lipoprotein receptor fragment. Successful refolding of a functionally active ligand-binding domain produced in Escherichia coli |
Q36314748 | Human low-density lipoprotein receptor gene and its regulation |
Q24339643 | Human lysozyme: sequencing of a cDNA, and expression and secretion by Saccharomyces cerevisiae |
Q24535259 | Human meprin beta: O-linked glycans in the intervening region of the type I membrane protein protect the C-terminal region from proteolytic cleavage and diminish its secretion |
Q35572780 | Human nidogen: complete amino acid sequence and structural domains deduced from cDNAs, and evidence for polymorphism of the gene |
Q29619449 | Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A |
Q68093258 | Human pregnancy-specific beta 1-glycoprotein: a new member of the carcinoembryonic antigen gene family |
Q40833413 | Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2. |
Q24315915 | Human signal recognition particle (SRP) Alu-associated protein also binds Alu interspersed repeat sequence RNAs. Characterization of human SRP9 |
Q29615235 | Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery |
Q41998866 | IDENTIFICATION AND EXPRESSION ANALYSIS OF VITELLOGENIN RECEPTOR FROM THE WILD SILKWORM, Bombyx mandarina |
Q73600046 | Identification and characterization of LDL receptor gene mutations in hyperlipidemic Chinese |
Q54572671 | Identification and characterization of novel low-density lipoprotein receptor mutations of familial hypercholesterolaemia patients in Taiwan. |
Q39870683 | Identification and characterization of the viral interaction determinant of the subgroup A avian leukosis virus receptor |
Q28744540 | Identification and functional characterization in vivo of a novel splice variant of LDLR in rhesus macaques |
Q36720307 | Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6) |
Q33845952 | Identification and sequence analysis of a second form of prolactin receptor by molecular cloning of complementary DNA from rabbit mammary gland |
Q69376763 | Identification of LDL receptor gene marker associated with altered levels of LDL cholesterol and apolipoprotein B in baboons |
Q34411329 | Identification of Ubxd8 protein as a sensor for unsaturated fatty acids and regulator of triglyceride synthesis |
Q69915127 | Identification of a deletion in the LDL receptor gene. A Finnish type of mutation |
Q70096812 | Identification of a deletion in the low density lipoprotein (LDL) receptor gene in a patient with familial hypercholesterolaemia |
Q73332523 | Identification of a double mutation in the low-density lipoprotein receptor gene causing familial hypercholesterolemia |
Q24290727 | Identification of a novel exon in apolipoprotein E receptor 2 leading to alternatively spliced mRNAs found in cells of the vascular wall but not in neuronal tissue |
Q36369960 | Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells |
Q71087468 | Identification of a novel mutation in exon 13 of the LDL receptor gene causing familial hypercholesterolemia in two Spanish families |
Q33867154 | Identification of a point mutation in growth factor repeat C of the low density lipoprotein-receptor gene in a patient with homozygous familial hypercholesterolemia that affects ligand binding and intracellular movement of receptors |
Q38343413 | Identification of a second "French Canadian" LDL receptor gene deletion and development of a rapid method to detect both deletions. |
Q68015548 | Identification of a silent point mutation in the LDL-receptor gene by direct DNA sequencing |
Q46528277 | Identification of deletions and duplications in the low density lipoprotein receptor gene by MLPA. |
Q41924391 | Identification of deletions in the human low density lipoprotein receptor gene |
Q73715661 | Identification of four novel mutations of the low-density lipoprotein receptor gene in Korean patients with familial hypercholesterolemia |
Q69636483 | Identification of low density lipoprotein receptor binding domains of human apolipoprotein B-100: a proposed consensus LDL receptor binding sequence of apoB-100 |
Q34979050 | Identification of luminal Loop 1 of Scap protein as the sterol sensor that maintains cholesterol homeostasis |
Q33399670 | Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements |
Q38728542 | Identification of roles for H264, H306, H439, and H635 in acid-dependent lipoprotein release by the LDL receptor. |
Q40546017 | Identification of the human rhinovirus serotype 1A binding site on the murine low-density lipoprotein receptor by using human-mouse receptor chimeras |
Q28238318 | Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry |
Q74127852 | Identification of three mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia among French Canadians |
Q73346250 | Identification of two LDL receptor mutations causing familial hypercholesterolemia in Indian subjects |
Q73441582 | Identification of two novel LDL receptor gene defects in French-Canadian pediatric population: mutational analysis and biochemical studies |
Q41065774 | Immortalized rat proximal tubule cells produce membrane bound and soluble megalin |
Q56969941 | Immune Interferon Receptor: Chemical and Enzymatic Sensitivity |
Q40925711 | Impaired regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation in lovastatin-resistant cells |
Q37130604 | Importance of growth hormone for the induction of hepatic low density lipoprotein receptors |
Q34492190 | Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange |
Q26781446 | In a Class of Their Own - RXFP1 and RXFP2 are Unique Members of the LGR Family |
Q68406513 | In vitro processing of tropoelastin: investigation of a possible transport function associated with the carboxy-terminal domain |
Q42489938 | In vivo and in vitro phosphorylation of murine lymphocyte differentiation antigen CD5. |
Q68324641 | In vivo regulation of low-density lipoprotein receptor and apolipoprotein B gene expressions by dietary fat and cholesterol in inbred strains of mice |
Q40944660 | Inactivation of the gene encoding the flagellar pocket protein, CRAM, in African trypanosomes |
Q72210551 | Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit |
Q35589157 | Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha-ethinyl estradiol |
Q39563830 | Initiation of coagulation by tissue factor |
Q37345649 | Insect vitellogenin/lipophorin receptors: molecular structures, role in oogenesis, and regulatory mechanisms |
Q28251165 | Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme a reductase stimulated by delta- and gamma-tocotrienols |
Q44620965 | Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol |
Q36796007 | Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol |
Q33880454 | Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity |
Q28285510 | Insulin-like growth factor II receptor as a multifunctional binding protein |
Q51763093 | Interaction between the ligand-binding domain of the LDL receptor and the C-terminal domain of PCSK9 is required for PCSK9 to remain bound to the LDL receptor during endosomal acidification. |
Q41508418 | Interaction of a 39 kDa protein with the low-density-lipoprotein-receptor-related protein (LRP) on rat hepatoma cells |
Q69780838 | Interaction of human low density lipoprotein and apolipoprotein B with ternary lipid microemulsion. Physical and functional properties |
Q58023267 | Internalization of the anticoagulant thrombomodulin is constitutive and does not require a signal in the cytoplasmic domain |
Q44534068 | Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4. |
Q34195375 | Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain |
Q35383835 | International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides. |
Q39984867 | Intracellular trafficking of LRP9 is dependent on two acidic cluster/dileucine motifs |
Q39737311 | Introduction to the plasma lipoproteins |
Q39764520 | Intron-dependent evolution: preferred types of exons and introns |
Q54765769 | Investigation of the distribution and changes of VLDLR subtype in fibrotic cardiac muscles. |
Q36756891 | Involvement of second messengers in regulation of the low-density lipoprotein receptor gene |
Q42819400 | Is vitellogenin an ancestor of apolipoprotein B-100 of human low-density lipoprotein and human lipoprotein lipase? |
Q24563737 | Isolation and characterization of a cDNA encoding the low molecular weight insulin-like growth factor binding protein (IBP-1) |
Q24610708 | Isolation and characterization of cDNA clones encoding the human carcinoembryonic antigen reveal a highly conserved repeating structure |
Q69441252 | Isolation and characterization of four heparin-binding cyanogen bromide peptides of human plasma apolipoprotein B |
Q24613496 | Isolation and characterization of full-length functional cDNA clones for human carcinoembryonic antigen |
Q36773167 | Isolation and cloning by a polymerase chain reaction of a genomic DNA fragment of the human slow skeletal troponin (TNNT1) gene |
Q69647871 | Isolation of a proteolytically derived domain of the insulin receptor containing the major site of cross-linking/binding |
Q38338865 | Isolation of an Alu repetitive DNA binding protein and effect of CpG methylation on binding to its recognition sequence |
Q28115591 | Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA |
Q24296254 | Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1/Leu-1 |
Q28271399 | Isolation of mutant cells lacking Insig-1 through selection with SR-12813, an agent that stimulates degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase |
Q36489597 | Isolation of the human insulin-like growth factor genes: insulin-like growth factor II and insulin genes are contiguous |
Q36836992 | Italian population data on the loci LDLR, GYPA, HBGG, D7S8 and GC. |
Q30583186 | Jordanian population data on the PCR-based loci: LDLR, GYPA, HBGG, D7S8 and GC. |
Q41493922 | Ketoconazole and 25-hydroxycholesterol produce reciprocal changes in the rate of transcription of the human LDL receptor gene |
Q58842957 | LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation |
Q24321832 | LDL receptor/lipoprotein recognition: endosomal weakening of ApoB and ApoE binding to the convex face of the LR5 repeat |
Q41621196 | LDL receptors in keratinocytes |
Q68802373 | LDL-receptor mRNA expression in liver regeneration after partial hepatectomy |
Q35938094 | LDL-receptor mutations in Europe |
Q34650934 | LDLR Database (second edition): new additions to the database and the software, and results of the first molecular analysis |
Q33521909 | LDLR expression and localization are altered in mouse and human cell culture models of Alzheimer's disease |
Q28507759 | LRAD3, a novel low-density lipoprotein receptor family member that modulates amyloid precursor protein trafficking |
Q72764283 | LRP and the receptor-mediated endocytosis of plasminogen activators |
Q41941559 | Ligand selectivity of 105 kDa and 130 kDa lipoprotein-binding proteins in vascular-smooth-muscle-cell membranes is unique |
Q42675685 | Ligand-binding domains in vitellogenin receptors and other LDL-receptor family members share a common ancestral ordering of cysteine-rich repeats |
Q63915864 | Ligand-receptor interactions of the low density lipoprotein receptor-related protein, a multi-ligand endocytic receptor |
Q46001391 | Linkage disequilibrium between DNA markers at the low-density lipoprotein receptor gene. |
Q33889684 | Lipid transport biochemistry and its role in energy production |
Q39593380 | Lipid-lowering and antioxidant activities of Jiang-Zhi-Ning in Traditional Chinese Medicine |
Q39700049 | Lipoproteins and atherosclerosis |
Q43711521 | Lipoproteins, malignancy, and anticancer agents. |
Q24611424 | Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia |
Q44059750 | Localization of PEPD to the long arm of chromosome 19. |
Q73977884 | Localization of the N-terminal domain of the low density lipoprotein receptor |
Q61981672 | Location of mouse and human genes corresponding to conserved canine olfactory receptor gene subfamilies |
Q64380847 | Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade |
Q77739511 | Lovastatin decreases the receptor-mediated degradation of acetylated and oxidized LDLs in human blood monocytes during the early stage of differentiation into macrophages |
Q71210052 | Lovastatin reduces expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells |
Q29014323 | Low Density Lipoprotein Receptor-related Protein/[IMAGE][IMAGE]-Macroglobulin Receptor Mediates the Cellular Internalization and Degradation of Thrombospondin |
Q70883747 | Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels are coordinately reduced in human renal cell carcinoma |
Q36531164 | Low density lipoprotein receptor and cation-independent mannose 6-phosphate receptor are transported from the cell surface to the Golgi apparatus at equal rates in PC12 cells |
Q40972546 | Low density lipoprotein receptor as a candidate receptor for hepatitis C virus |
Q24609758 | Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins |
Q37149561 | Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator |
Q33758610 | Low density lipoprotein uptake: holoparticle and cholesteryl ester selective uptake |
Q77996963 | Low density lipoprotein-receptor plays a major role in the binding of very low density lipoproteins and their remnants on HepG2 cells |
Q54131876 | Low-density lipoprotein endocytosis. I. Influence of the multivalent ligand cationized ferritin on normal and receptor-negative human fibroblasts. |
Q43714958 | Low-density lipoprotein receptor gene mutation analysis and structure-function correlation in an Omani arab family with familial hypercholesterolemia |
Q38139022 | Low-density lipoprotein receptors in liver: old acquaintances and a newcomer |
Q53264107 | Low-density lipoprotein-mimicking nanoparticles for tumor-targeted theranostic applications. |
Q36196801 | Lrp13 is a novel vertebrate lipoprotein receptor that binds vitellogenins in teleost fishes |
Q60045905 | Lucky, times ten: A career in Texas science |
Q56531227 | Lysosomal cholesterol export reconstituted from fragments of Niemann-Pick C1 |
Q41680284 | MIG-13 positions migrating cells along the anteroposterior body axis of C. elegans |
Q47730212 | Major components of a sea urchin block to polyspermy are structurally and functionally conserved |
Q50635229 | Mapping key regions of the RXFP2 low-density lipoprotein class-A module that are involved in signal activation. |
Q71601016 | Mapping of the 19p13 breakpoint in an ovarian carcinoma between the INSR and TCF3 loci |
Q61982671 | Marked association of a RFLP for the low density lipoprotein receptor gene with obesity in essential hypertensives |
Q36814824 | Mechanism and consequences of the duplication of the human C4/P450c21/gene X locus |
Q41833733 | Mechanism of LDL binding and release probed by structure-based mutagenesis of the LDL receptor |
Q38289814 | Mechanism of low density lipoprotein (LDL) release in the endosome: implications of the stability and Ca2+ affinity of the fifth binding module of the LDL receptor. |
Q36767518 | Mechanisms of disease: genetic causes of familial hypercholesterolemia |
Q41758467 | Megalin-mediated endocytosis in renal proximal tubule |
Q35077224 | Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus |
Q57212598 | Membrane attack complex-associated molecules from redlip mullet (Liza haematocheila): Molecular characterization and transcriptional evidence of C6, C7, C8β, and C9 in innate immunity |
Q24318004 | Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype |
Q40737575 | Membrane proteins that protect against complement lysis |
Q41718862 | Membrane receptors for endocytosis in the renal proximal tubule. |
Q38181066 | Membrane receptors for extracellular matrix macromolecules: relationship to cell adhesion and tumor metastasis |
Q40939802 | Membrane topology of S2P, a protein required for intramembranous cleavage of sterol regulatory element-binding proteins |
Q24293757 | Membrane-associated ubiquitin ligase complex containing gp78 mediates sterol-accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase |
Q28075743 | Metabolism and Modification of Apolipoprotein B-Containing Lipoproteins Involved in Dyslipidemia and Atherosclerosis |
Q24628996 | Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits |
Q37379761 | Mitotic Golgi disassembly is required for bipolar spindle formation and mitotic progression |
Q44513963 | Modified linear polyethylenimine-cholesterol conjugates for DNA complexation |
Q35236987 | Modular transposition and the dynamical structure of eukaryote regulatory evolution |
Q42078686 | Modulation of complement regulatory function and measles virus receptor function by the serine-threonine-rich domains of membrane cofactor protein (CD46). |
Q42475999 | Modulation of juxtamembrane cleavage ("shedding") of angiotensin-converting enzyme by stalk glycosylation: evidence for an alternative shedding protease. |
Q37201945 | Molecular Genetics of Familial Hypercholesterolemia |
Q58159389 | Molecular Genetics of Hypercholesterolemia |
Q48275942 | Molecular analysis of deletions in the human beta-globin gene cluster: deletion junctions and locations of breakpoints |
Q39737316 | Molecular and cell biology of lipoprotein biosynthesis |
Q36401301 | Molecular and cellular mechanisms of receptor-mediated endocytosis |
Q27742097 | Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module |
Q36265507 | Molecular basis of familial hypercholesterolemia: An Indian experience |
Q39819750 | Molecular biology in arteriosclerosis research |
Q39559628 | Molecular biology of human apolipoprotein B and related diseases. |
Q38327290 | Molecular biology of human apolipoproteins B and E and associated diseases of lipoprotein metabolism. |
Q24567485 | Molecular characterization of a gene of the 'EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cells |
Q34556697 | Molecular characterization of human Ro/SS-A antigen. Amino terminal sequence of the protein moiety of human Ro/SS-A antigen and immunological activity of a corresponding synthetic peptide |
Q35644390 | Molecular characterization of minor gene rearrangements in Finnish patients with heterozygous familial hypercholesterolemia: identification of two common missense mutations (Gly823-->Asp and Leu380-->His) and eight rare mutations of the LDL receptor |
Q44460218 | Molecular characterization of the first avian LDL receptor: role in sterol metabolism of ovarian follicular cells. |
Q37378425 | Molecular characterization of the mosquito vitellogenin receptor reveals unexpected high homology to the Drosophila yolk protein receptor |
Q22004159 | Molecular cloning and characterization of LR3, a novel LDL receptor family protein with mitogenic activity |
Q22254880 | Molecular cloning and characterization of the human dbl proto-oncogene: evidence that its overexpression is sufficient to transform NIH/3T3 cells |
Q30359832 | Molecular cloning and developmental expression pattern of the vitellogenin receptor from the cockroach, Leucophaea maderae. |
Q24303604 | Molecular cloning and expression of a receptor for human tumor necrosis factor |
Q42816749 | Molecular cloning and nucleotide sequence of cDNA encoding a functional murine low-density-lipoprotein receptor |
Q42607414 | Molecular cloning and partial characterization of an ovarian receptor with seven ligand binding repeats, an orthologue of low-density lipoprotein receptor, in the cutthroat trout (Oncorhynchus clarki). |
Q34638898 | Molecular cloning and sequence analysis of the catalytic subunit of bovine type 2A protein phosphatase |
Q36424232 | Molecular cloning and structure of the human interleukin 2 receptor gene |
Q34585890 | Molecular cloning of Ly-1, a membrane glycoprotein of mouse T lymphocytes and a subset of B cells: molecular homology to its human counterpart Leu-1/T1 (CD5). |
Q28299349 | Molecular cloning of cDNA for human complement component C1s. The complete amino acid sequence |
Q30406574 | Molecular cloning of human apolipoprotein B cDNA. |
Q33894003 | Molecular cloning of the large subunit of transforming growth factor type beta masking protein and expression of the mRNA in various rat tissues |
Q50659511 | Molecular cloning, characterization and regulation of the cockroach vitellogenin receptor during oogenesis. |
Q34257677 | Molecular counting of low-density lipoprotein particles as individuals and small clusters on cell surfaces |
Q45759199 | Molecular evolution of the carbonic anhydrase genes: calculation of divergence time for mouse carbonic anhydrase I and II. |
Q78476892 | Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population |
Q73589355 | Molecular genetic testing for familial hypercholesterolemia: spectrum of LDL receptor gene mutations in The Netherlands |
Q28207758 | Molecular genetics of the LDL receptor gene in familial hypercholesterolemia |
Q38162125 | Molecular mechanisms of cytolysis by complement and by cytolytic lymphocytes |
Q37972887 | Molecular pathology of familial hypercholesterolemia, related dyslipidemias and therapies beyond the statins |
Q34557404 | More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration |
Q28237952 | Mouse and human CD14 (myeloid cell-specific leucine-rich glycoprotein) primary structure deduced from cDNA clones |
Q37121194 | Mouse macrophage receptor for acetylated low density lipoprotein: demonstration of a fully functional subunit in the membrane and with purified receptor |
Q28238473 | Mouse very-low-density-lipoprotein receptor (VLDLR) cDNA cloning, tissue-specific expression and evolutionary relationship with the low-density-lipoprotein receptor |
Q35586870 | Multiple crm- mutations in familial hypercholesterolemia. Evidence for 13 alleles, including four deletions |
Q36424372 | Murine plasma cell membrane antigen PC-1: molecular cloning of cDNA and analysis of expression |
Q33878706 | Mutant oocytic low density lipoprotein receptor gene family member causes atherosclerosis and female sterility |
Q58143918 | Mutant transcripts of the LDL receptor gene: mRNA structure and quantity |
Q40419629 | Mutation G805R in the transmembrane domain of the LDL receptor gene causes familial hypercholesterolemia by inducing ectodomain cleavage of the LDL receptor in the endoplasmic reticulum |
Q26269836 | Mutation in LDL receptor: Alu-Alu recombination deletes exons encoding transmembrane and cytoplasmic domains |
Q50950950 | Mutation p.L799R in the LDLR, which affects the transmembrane domain of the LDLR, prevents membrane insertion and causes secretion of the mutant LDLR. |
Q61387686 | Mutation screening of the LDLR gene and ApoB gene in patients with a phenotype of familial hypercholesterolemia and normal values in a functional LDL receptor/apolipoprotein B assay |
Q38346504 | Mutational analysis of the ligand binding domain of the low density lipoprotein receptor |
Q38939832 | Mutational heterogeneity in low-density lipoprotein receptor gene related to familial hypercholesterolemia in Morocco. |
Q68616089 | Mutations in the low density lipoprotein receptor gene in Japanese patients with familial hypercholesterolemia |
Q77393956 | Mutations in the low-density lipoprotein receptor gene in Swedish familial hypercholesterolaemia patients: clinical expression and treatment response |
Q81067930 | Mutations of the low-density-lipoprotein receptor gene and familial hypercholesterolemia |
Q46603259 | Native and oxidized low-density lipoproteins stimulate endothelin-converting enzyme-1 expression in human endothelial cells. |
Q44744920 | Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit |
Q28116105 | Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing |
Q73507862 | Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated |
Q93697284 | New genetics of the hyperlipidaemias and diabetes |
Q77393946 | New type of the internalization-defective low-density lipoprotein receptor owing to two-nucleotide deletion (2199delCA or 2201delCA) in Japanese patients with familial hypercholesterolaemia |
Q69821234 | New variant of low density lipoprotein receptor gene. FH-Tonami |
Q34139012 | No requirement for localized Nudel protein expression in Drosophila embryonic axis determination |
Q68751567 | Novel gene mutations at the low density lipoprotein receptor locus: FH-Kanazawa and FH-Okayama |
Q43216594 | Novel mutations identification in exon 4 of LDLR gene in patients with moderate hypercholesterolemia in a Venezuelan population |
Q36952435 | Nucleotide sequence and expression in vitro of cDNA derived from mRNA of int-1, a provirally activated mouse mammary oncogene |
Q40521487 | Nucleotide sequence of the rat low density lipoprotein receptor cDNA. |
Q46609130 | O-glycosylation and stability. Unfolding of glucoamylase induced by heat and guanidine hydrochloride |
Q38330153 | O-glycosylation in Aspergillus glucoamylase. Conformation and role in binding |
Q36876622 | O-linked glycosylation of retroviral envelope gene products |
Q70160601 | Oncogene proteins and the insulin receptor |
Q39547546 | Oncogenes and urological malignancies: implications for the future |
Q28361629 | Optional exon in the 5'-untranslated region of 3-hydroxy-3-methylglutaryl coenzyme A synthase gene: conserved sequence and splicing pattern in humans and hamsters |
Q34175241 | Overexpression of low density lipoprotein (LDL) receptor eliminates LDL from plasma in transgenic mice |
Q73409190 | Overexpression of low density lipoprotein receptor eliminates apolipoprotein B100-containing lipoproteins from circulation and markedly prevents early atherogenesis in apolipoprotein E-deficient mice |
Q68000543 | Overexpression of low density lipoprotein receptor on Chinese hamster ovary cells generates foam cells |
Q98392269 | Ovotransferrin Exhibits Osteogenic Activity Partially via LDL Receptor-related Protein 1 (LRP1) Activation in MC3T3-E1 Cells |
Q35042005 | Oxidized low-density lipoproteins: what is understood and what remains to be clarified |
Q77601534 | Oxidized phospholipids as a new landmark in atherosclerosis |
Q36851164 | Oxysterols, cholesterol homeostasis, and Alzheimer disease |
Q33807223 | Oxysterols: modulators of cholesterol metabolism and other processes |
Q41691951 | PCR primers for human chromosomes: reagents for the rapid analysis of somatic cell hybrids |
Q36847452 | Pathway of B1-Alu expression in microinjected oocytes: Xenopus laevis proteins associated with nuclear precursor and processed cytoplasmic RNAs |
Q36213211 | Perinuclear location and recycling of epidermal growth factor receptor kinase: immunofluorescent visualization using antibodies directed to kinase and extracellular domains |
Q53207672 | Perlecan: the multidomain heparan sulphate proteoglycan of basement membrane and extracellular matrix. |
Q71637229 | Phenotypic presentation of the FH-Cincinnati type 5 low density lipoprotein receptor mutation |
Q42685552 | Phorbol ester-induced juxtamembrane cleavage of angiotensin-converting enzyme is not inhibited by a stalk containing intrachain disulfides. |
Q90434768 | Phosphatidylinositol-(4,5)-Bisphosphate Regulates Plasma Cholesterol Through LDL (Low-Density Lipoprotein) Receptor Lysosomal Degradation |
Q34325673 | Phospholipase D2 is required for efficient endocytic recycling of transferrin receptors |
Q51562587 | Plasma anti-α-galactoside antibody mediates lipoprotein(a) binding to macrophages. |
Q68521024 | Plasma cholesterol-lowering activity of monocyte colony-stimulating factor (M-CSF) |
Q34869224 | Pleiotrophin as a central nervous system neuromodulator, evidences from the hippocampus. |
Q36850216 | Point mutation in luminal loop 7 of Scap protein blocks interaction with loop 1 and abolishes movement to Golgi |
Q35247208 | Polymorphic DNA haplotypes at the LDL receptor locus |
Q35194175 | Polymorphic haplotypes and recombination rates at the LDL receptor gene locus in subjects with and without familial hypercholesterolemia who are from different populations |
Q37555170 | Polymorphism and evolution of Alu sequences in the human low density lipoprotein receptor gene |
Q36817143 | Population data on the PCR-based loci LDLR GYPA, HBGG, D7S8, Gc, HLA-DQA1, and D1S80 from Arabs from Dubai |
Q36216556 | Potassium-dependent assembly of coated pits: new coated pits form as planar clathrin lattices |
Q35756612 | Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake |
Q34347050 | Preferential sites of proteolytic cleavage of bovine, human and rat thyroglobulin. The use of limited proteolysis to detect solvent-exposed regions of the primary structure |
Q67533720 | Prevalence and geographical distribution of major LDL receptor gene rearrangements in Finland |
Q77322368 | Prevalence of Lithuanian mutation among St. Petersburg Jews with familial hypercholesterolemia |
Q72189535 | Primary dual defect of cholesterol and bile acid metabolism in liver of patients with intrahepatic calculi |
Q48376190 | Primary structure of bovine thyroglobulin deduced from the sequence of its 8,431-base complementary DNA. |
Q33929176 | Primary structure of the gene for the murine Ia antigen-associated invariant chains (Ii). An alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin |
Q42616828 | Products of the unc-52 gene in Caenorhabditis elegans are homologous to the core protein of the mammalian basement membrane heparan sulfate proteoglycan |
Q39702041 | Progress in understanding mechanisms of the serum cholesterol risk factor in atherosclerosis |
Q43631774 | Protective effects of Saiko-ka-ryukotsu-borei-to (Chai-Hu-Jia-Long-Gu-Mu-Li-Tang) against atherosclerosis in Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits |
Q68763588 | Protein domains of the low density lipoprotein receptor |
Q71477938 | Protein folding and calcium binding defects arising from familial hypercholesterolemia mutations of the LDL receptor |
Q39503984 | Protein kinase activity of the insulin receptor |
Q30403445 | Proteins, exons and molecular evolution |
Q40910738 | Proteoglycans of basement membranes |
Q36871737 | Proteolytic release of membrane proteins: studies on a membrane-protein-solubilizing activity in CHO cells |
Q36813409 | Proteolytic release of membrane-bound angiotensin-converting enzyme: role of the juxtamembrane stalk sequence |
Q101565149 | Proteostasis Regulation in the Endoplasmic Reticulum: An Emerging Theme in the Molecular Pathology and Therapeutic Management of Familial Hypercholesterolemia |
Q40419031 | Pst I RFLP close to the LDL receptor gene |
Q41979573 | Purification of a putative lipoprotein receptor from Schistosoma japonicum adult worms |
Q69927422 | Pvu II polymorphism of low density lipoprotein receptor gene and familial hypercholesterolemia. Study of Italians |
Q34324828 | Quantitation of mRNA by the polymerase chain reaction |
Q38350285 | Quantitation of the sterol regulatory element-binding protein mRNA in mononuclear blood cells by competitive RT-PCR |
Q40567291 | RFLP for the human LDL receptor gene (LDLR): Bst EII. |
Q37716069 | RNAi therapeutics for CNS disorders |
Q36597924 | RNAi therapy for neurodegenerative diseases. |
Q24293268 | Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity |
Q69352440 | Radiation inactivation of membrane components and molecular mass determination by target analysis |
Q69583976 | Radiation target analysis of glycoproteins |
Q104267397 | Rapid degradation of GRASP55 and GRASP65 reveals their immediate impact on the Golgi structure |
Q68162143 | Rearrangements in the LDL receptor gene in Dutch familial hypercholesterolemic patients and the presence of a common 4 kb deletion |
Q89775505 | Recent advances in genome editing for cardiovascular disease |
Q43916702 | Receptor mediated yolk protein uptake in the crab Scylla serrata: crustacean vitellogenin receptor recognizes related mammalian serum lipoproteins |
Q71246704 | Receptor-associated protein is a folding chaperone for low density lipoprotein receptor-related protein |
Q34554723 | Receptor-independent low density lipoprotein transport in the rat in vivo. Quantitation, characterization, and metabolic consequences |
Q69875511 | Receptor-mediated endocytosis |
Q40886690 | Receptor-mediated endocytosis in the procyclic form of Trypanosoma brucei |
Q28283978 | Receptors compete for adaptors found in plasma membrane coated pits |
Q33647536 | Receptors for the host low density lipoproteins on the hemoflagellate Trypanosoma brucei: purification and involvement in the growth of the parasite |
Q40969377 | Recognition of the carboxyl-terminal signal for GPI modification requires translocation of its hydrophobic domain across the ER membrane |
Q40966970 | Recombinant soluble low-density lipoprotein receptor fragment inhibits common cold infection |
Q84829637 | Reduced penetrance of autosomal dominant hypercholesterolemia in a high percentage of families: importance of genetic testing in the entire family |
Q69890182 | Regional localisations and linkage relationships of seven RFLPs and myotonic dystrophy on chromosome 19 |
Q37454290 | Regulated endoplasmic reticulum-associated degradation of a polytopic protein: p97 recruits proteasomes to Insig-1 before extraction from membranes |
Q28320785 | Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes |
Q41624566 | Regulation of LDL receptor, apoB, and apoE protein and mRNA in Hep G2 cells |
Q41467015 | Regulation of intracellular cholesterol metabolism is defective in lymphoblasts from Niemann-Pick type C and type D patients. |
Q39027013 | Regulation of low density lipoprotein receptor and cytochrome P-450scc mRNA levels in human granulosa cells |
Q52182903 | Regulation of low density lipoprotein receptor mRNA levels by estradiol 17beta and chorionic gonadotropin in human placenta. |
Q41670480 | Regulation of low-density lipoprotein receptor expression during keratinocyte differentiation |
Q71841082 | Regulation of low-density lipoprotein receptors and assessment of their functional role in Burkitt's lymphoma cells |
Q69206595 | Regulation of low-density lipoprotein receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis |
Q69075101 | Regulation of low-density-lipoprotein-receptor mRNA by insulin in human hepatoma Hep G2 cells |
Q73201506 | Regulation of pathways determining cholesterol availability in the baboon placenta with advancing gestation |
Q33836673 | Regulation of the low density lipoprotein receptor and hydroxymethylglutaryl coenzyme A reductase genes by protein kinase C and a putative negative regulatory protein |
Q30404028 | Relationships between the gene and protein structure in human complement component C9. |
Q38072905 | Relaxin family peptides and their receptors |
Q38160366 | Removal of the Alu structural domain from signal recognition particle leaves its protein translocation activity intact. |
Q57454815 | Replacement of cysteine at position 46 in the first cysteine-rich repeat of the LDL receptor impairs apolipoprotein recognition |
Q68303284 | Retroviral vector-mediated in vivo expression of low-density-lipoprotein receptors in the Watanabe heritable hyperlipidemic rabbit |
Q64382900 | Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor |
Q39774353 | Revision of consensus sequence of human Alu repeats--a review |
Q35312862 | Role of cellular cholesterol metabolism in vascular cell calcification |
Q72396953 | Role of common genetic polymorphisms in the LDL receptor gene in affecting plasma cholesterol levels in the general population |
Q40782405 | Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. |
Q46264980 | Role of receptor-associated 39/45 kD protein in active Heymann nephritis |
Q35553097 | Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse |
Q33888529 | Roles for trafficking and O-linked glycosylation in the turnover of model cell surface proteins |
Q38598477 | Roles of Lipoproteins and Apolipoproteins in Particle Formation of Hepatitis C Virus |
Q38985597 | Roles of lipoprotein and apolipoprotein in HCV infection |
Q50721166 | SFE1, a constituent of the fertilization envelope in the sea urchin is made by oocytes and contains low-density lipoprotein-receptor-like repeats. |
Q38360185 | SREBP-1 mediates activation of the low density lipoprotein receptor promoter by insulin and insulin-like growth factor-I. |
Q24310555 | SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis |
Q37651101 | SRL-Coated PAMAM Dendrimer Nano-Carrier for Targeted Gene Delivery to the Glioma Cells and Competitive Inhibition by Lactoferrin |
Q24305281 | ST7 is a novel low-density lipoprotein receptor-related protein (LRP) with a cytoplasmic tail that interacts with proteins related to signal transduction pathways |
Q90436782 | Schnyder Corneal Dystrophy-Associated UBIAD1 is Defective in MK-4 Synthesis and Resists Autophagy-Mediated Degradation |
Q70221901 | Screening for a prevalent LDL receptor mutation in patients with severe hypercholesterolaemia |
Q72333208 | Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia |
Q33676595 | Screening for mutations in exon 4 of the LDL receptor gene: identification of a new deletion mutation. |
Q72231133 | Screening for point mutations in exon 10 of the low density lipoprotein receptor gene by analysis of single-strand conformation polymorphisms: detection of a nonsense mutation-FH469-->Stop |
Q35020203 | Sequence and structure of human rhinoviruses reveal the basis of receptor discrimination |
Q24339620 | Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors |
Q24290202 | Sequence similarities between a novel putative G protein-coupled receptor and Na+/Ca2+ exchangers define a cation binding domain |
Q69868179 | Sequence similarity between epidermal growth factor precursor and atrial natriuretic factor precursor |
Q64085599 | Sequential disruption of ALV host receptor genes reveals no sharing of receptors between ALV subgroups A, B, and J |
Q48224334 | Serial Alu sequence transposition interrupting a human B creatine kinase pseudogene |
Q44303467 | Serine proteases and their homologs in the Drosophila melanogaster genome: an initial analysis of sequence conservation and phylogenetic relationships |
Q36720405 | Serpin A1 and CD91 as host instruments against HIV-1 infection: are extracellular antiviral peptides acting as intracellular messengers? |
Q71725568 | Seven DNA polymorphisms in the LDL receptor gene: application to the study of familial hypercholesterolemia in Spain |
Q78753350 | Sex and hormonal status modulate the effects of psyllium on plasma lipids and monocyte gene expression in humans |
Q35228909 | Signal Transduction by the Colony-Stimulating Factor-1 Receptor; Comparison to Other Receptor Tyrosine Kinases |
Q48369441 | Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor |
Q74455513 | Simplified detection of a mutation causing familial hypercholesterolaemia throughout Britain: evidence for an origin in a common distant ancestor |
Q33595177 | Six DNA polymorphisms in the low density lipoprotein receptor gene: their genetic relationship and an example of their use for identifying affected relatives of patients with familial hypercholesterolaemia |
Q39718607 | Software and database for the analysis of mutations in the human LDL receptor gene |
Q52566959 | Soluble LDL minireceptors. Minimal structure requirements for recognition of minor group human rhinovirus. |
Q27632923 | Solution structure of the LDL receptor EGF-AB pair: a paradigm for the assembly of tandem calcium binding EGF domains |
Q27621667 | Solution structure of the sixth LDL-A module of the LDL receptor |
Q33731030 | Somatic gene therapy for dyslipidemias |
Q34438706 | Sorting an LDL receptor with bound PCSK9 to intracellular degradation |
Q37372140 | SpCoel1: a sea urchin profilin gene expressed specifically in coelomocytes in response to injury |
Q83655936 | Species differences of macrophage very low-density-lipoprotein (VLDL) receptor protein expression |
Q39684168 | Species-specific receptor recognition by a minor-group human rhinovirus (HRV): HRV serotype 1A distinguishes between the murine and the human low-density lipoprotein receptor |
Q42806879 | Specific EGF repeats of Notch mediate interactions with Delta and serrate: Implications for notch as a multifunctional receptor |
Q40817578 | Specificity of binding of clathrin adaptors to signals on the mannose-6-phosphate/insulin-like growth factor II receptor |
Q40895692 | Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells |
Q35651427 | Sterol-induced degradation of HMG CoA reductase depends on interplay of two Insigs and two ubiquitin ligases, gp78 and Trc8. |
Q37270579 | Sterol-induced dislocation of 3-hydroxy-3-methylglutaryl coenzyme A reductase from membranes of permeabilized cells |
Q24306877 | Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78 |
Q92094495 | Strategies to prevent cleavage of the linker region between ligand-binding repeats 4 and 5 of the LDL receptor |
Q24339526 | Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus |
Q39698408 | Structural and functional aspects of epidermal growth factor (EGF) and its receptor. |
Q92527244 | Structural basis for itraconazole-mediated NPC1 inhibition |
Q41916799 | Structural basis for ligand capture and release by the endocytic receptor ApoER2. |
Q27660190 | Structural basis for specific recognition of reelin by its receptors |
Q33850785 | Structural homology of complement protein C6 with other channel-forming proteins of complement |
Q77293454 | Structural independence of ligand-binding modules five and six of the LDL receptor |
Q28292154 | Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor |
Q52250384 | Structural studies of detergent-solubilized and vesicle-reconstituted low-density lipoprotein (LDL) receptor. |
Q35205572 | Structure and dynamics of polypeptides and proteins in lipid membranes |
Q24556219 | Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation |
Q34650688 | Structure and physiologic function of the low-density lipoprotein receptor |
Q35610668 | Structure of a bovine gene for P-450c21 (steroid 21-hydroxylase) defines a novel cytochrome P-450 gene family |
Q27625423 | Structure of human rhinovirus serotype 2 (HRV2) |
Q28646488 | Structure of human steroid 21-hydroxylase genes |
Q34688924 | Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin |
Q27640067 | Structure of the LDL receptor extracellular domain at endosomal pH |
Q24643048 | Structure of the axonal surface recognition molecule neurofascin and its relationship to a neural subgroup of the immunoglobulin superfamily |
Q69404071 | Structure of the low-density lipoprotein receptor-related protein (LRP) promoter |
Q29616545 | Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors |
Q36465438 | Studies on rationales for an expert system approach to the interpretation of protein sequence data. Preliminary analysis of the human epidermal growth factor receptor |
Q24297663 | Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor |
Q36726735 | Swiss population data on the loci HLA-DQ alpha, LDLR, GYPA, HBGG, D7S8, Gc and D1S80. |
Q36848801 | Tandemly repeated exons encode 81-base repeats in multiple, developmentally regulated Schistosoma mansoni transcripts |
Q57248646 | TaqI polymorphism in the LDL receptor gene and a TaqI 1.5-kb band associated with familial hypercholesterolemia |
Q35096270 | Targeted disruption of the idol gene alters cellular regulation of the low-density lipoprotein receptor by sterols and liver x receptor agonists |
Q44640632 | Targeting of biotinylated compounds to its target tissue using a low-density lipoprotein receptor-avidin fusion protein |
Q39563083 | The 'BN2' gene, a regulator for the onset of chromosome condensation |
Q54336249 | The Arabic allele: a single base pair substitution activates a 10-base downstream cryptic splice acceptor site in exon 12 of LDLR and severely decreases LDLR expression in two unrelated Arab families with familial hypercholesterolemia. |
Q21735933 | The DNA sequence and biology of human chromosome 19 |
Q44815679 | The Drosophila EGF receptor gene homolog: conservation of both hormone binding and kinase domains |
Q34624656 | The Drosophila yolkless gene encodes a vitellogenin receptor belonging to the low density lipoprotein receptor superfamily |
Q68434690 | The Finnish type of the LDL receptor gene mutation: molecular characterization of the deleted gene and the corresponding mRNA |
Q35245419 | The Gordon Wilson Lecture. Plasma cholesterol: atherogenesis and mortality |
Q34196707 | The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors |
Q24658039 | The LDL receptor |
Q26269835 | The LDL receptor gene: a mosaic of exons shared with different proteins |
Q36160311 | The LDL receptor: how acid pulls the trigger |
Q83841386 | The Lebanese allele at the LDLR in normocholesterolemic people merits reconsideration of genotype phenotype correlations in familial hypercholesterolemia |
Q78019024 | The Lebanese mutation as an important cause of familial hypercholesterolemia in Brazil |
Q34448076 | The SRP9/14 subunit of the signal recognition particle (SRP) is present in more than 20-fold excess over SRP in primate cells and exists primarily free but also in complex with small cytoplasmic Alu RNAs |
Q34747495 | The UMD-LDLR database: additions to the software and 490 new entries to the database. |
Q28292114 | The VLDL receptor: an LDL receptor relative with eight ligand binding repeats, LR8 |
Q28291929 | The Very Low Density Lipoprotein Receptor Mediates the Cellular Catabolism of Lipoprotein Lipase and Urokinase-Plasminogen Activator Inhibitor Type I Complexes |
Q47840691 | The activity of HMG-CoA reductase and acetyl-CoA carboxylase in human apocrine sweat glands, sebaceous glands, and hair follicles is regulated by phosphorylation and by exogenous cholesterol |
Q40639637 | The adaptor protein beta-arrestin2 enhances endocytosis of the low density lipoprotein receptor |
Q40390784 | The alpha 2-macroglobulin receptor and epithelial glycoprotein-330: two giant receptors mediating endocytosis of multiple ligands |
Q95802452 | The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and the receptor-associated protein. An overview |
Q73417776 | The atherogenic lipoprotein phenotype is not caused by a mutation in the coding region of the low density lipoprotein receptor gene |
Q37398894 | The avian beta-adrenergic receptor: primary structure and membrane topology |
Q40675779 | The binding ability analysis of the normal VLDL receptor and its mutant |
Q35816823 | The binding of human low-density lipoproteins to the surface of schistosomula of Schistosoma mansoni is inhibited by polyanions and reduces the binding of anti-schistosomal antibodies |
Q78177602 | The carboxyl-terminal domain of receptor-associated protein facilitates proper folding and trafficking of the very low density lipoprotein receptor by interaction with the three amino-terminal ligand-binding repeats of the receptor |
Q39970114 | The citrus flavonoids hesperetin and nobiletin differentially regulate low density lipoprotein receptor gene transcription in HepG2 liver cells |
Q28115354 | The closed conformation of the LDL receptor is destabilized by the low Ca(++) concentration but favored by the high Mg(++) concentration in the endosome |
Q33881217 | The complete sequence and structural analysis of human apolipoprotein B-100: relationship between apoB-100 and apoB-48 forms. |
Q34620069 | The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule |
Q33654311 | The critical role of mRNA destabilizing protein heterogeneous nuclear ribonucleoprotein d in 3' untranslated region-mediated decay of low-density lipoprotein receptor mRNA in liver tissue. |
Q38073929 | The curation of genetic variants: difficulties and possible solutions |
Q33885414 | The cytoplasmic domain is not involved in directing Class 5 mutant LDL receptors to lysosomal degradation |
Q30442254 | The cytoplasmic domain of P-selectin contains a sorting determinant that mediates rapid degradation in lysosomes |
Q48022387 | The decrease of liver LDL receptor mRNA during fasting is related to the decrease in serum T3. |
Q36320640 | The distribution and characteristics of LDL receptor mutations in China: A systematic review |
Q77380919 | The distribution of circulating receptors on COS 7 cells |
Q38336827 | The dysfunctional LDL receptor in a monensin-resistant mutant of Chinese hamster ovary cells lacks selected O-linked oligosaccharides |
Q93501371 | The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells |
Q71866331 | The effects of inbreeding on DNA profile frequency estimates using PCR-based loci |
Q42749068 | The epidermal growth factor homology domain of the LDL receptor drives lipoprotein release through an allosteric mechanism involving H190, H562, and H586. |
Q38717124 | The evolution of egg yolk proteins |
Q35604030 | The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland |
Q43591687 | The first epidermal growth factor-like domain of the low-density lipoprotein receptor contains a noncanonical calcium binding site |
Q36925157 | The genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations. |
Q47398986 | The globulin seed storage proteins of flowering plants are derived from two ancestral genes |
Q41475128 | The helical hydrophobic moment avoids prolines in phospholipid-binding proteins |
Q24323959 | The human class I alcohol dehydrogenase gene cluster: three genes are tandemly organized in an 80-kb-long segment of the genome |
Q68182906 | The human insulin receptor cDNA: a new tool to study the function of this receptor |
Q28615445 | The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling |
Q39590486 | The human interleukin-2 receptor: analysis of structure and function |
Q38296407 | The hypocholesterolemic agent LY295427 reverses suppression of sterol regulatory element-binding protein processing mediated by oxysterols |
Q38335870 | The important role for betaVLDLs binding at the fourth cysteine of first ligand-binding domain in the low-density lipoprotein receptor |
Q38270837 | The insulin receptor: structure and function |
Q33930204 | The internalization of nerve growth factor by high-affinity receptors on pheochromocytoma PC12 cells. |
Q38360019 | The life cycle of the low-density lipoprotein receptor: insights from cellular and in-vivo studies |
Q38630175 | The low density lipoprotein receptor |
Q38334866 | The low density lipoprotein receptor in Xenopus laevis. I. Five domains that resemble the human receptor |
Q38692065 | The low density lipoprotein receptor: structure, function and pharmacological modulation |
Q47387240 | The lowering of plasma lipids following a weight reduction program is related to increased expression of the LDL receptor and lipoprotein lipase |
Q35116452 | The membrane-bound transcription factor CREB3L1 is activated in response to virus infection to inhibit proliferation of virus-infected cells. |
Q39338576 | The mode of action of nerve growth factor in PC12 cells |
Q38737709 | The molecular biology and biochemistry of tissue factor |
Q70323689 | The multiple origins of human Alu sequences |
Q42812960 | The neu oncogene encodes an epidermal growth factor receptor-related protein |
Q37422654 | The novel anticancer agent JNJ-26854165 induces cell death through inhibition of cholesterol transport and degradation of ABCA1 |
Q24555793 | The nucleotide sequence of the human int-1 mammary oncogene; evolutionary conservation of coding and non-coding sequences |
Q24679229 | The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate |
Q30244116 | The panorama of familial hypercholesterolemia in Latin America: a systematic review |
Q70163348 | The physical map of chromosome arm 19q: some new assignments, confirmations and re-assessments |
Q41872916 | The pore-forming protein (perforin) of cytolytic T lymphocytes is immunologically related to the components of membrane attack complex of complement through cysteine-rich domains |
Q35218996 | The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase |
Q24322953 | The primary structures of four subunits of the human, high-molecular-weight proteinase, macropain (proteasome), are distinct but homologous |
Q39836508 | The receptor model for transport of cholesterol in plasma |
Q40370626 | The regulation of stearoyl-CoA desaturase (SCD). |
Q49847466 | The relaxin receptor as a therapeutic target - perspectives from evolution and drug targeting |
Q30482054 | The repertoire of G protein-coupled receptors in the sea squirt Ciona intestinalis. |
Q40594748 | The role of a conserved acidic residue in calcium-dependent protein folding for a low density lipoprotein (LDL)-A module: implications in structure and function for the LDL receptor superfamily |
Q37357958 | The role of calcium in lipoprotein release by the low-density lipoprotein receptor |
Q39124393 | The role of registries and genetic databases in familial hypercholesterolemia |
Q24555815 | The sequence and topology of human complement component C9 |
Q36097802 | The structure of HSAG-1, a middle repetitive genetic element which elicits a leukemia-related cellular surface antigen |
Q28304137 | The sucrase-isomaltase complex: primary structure, membrane-orientation, and evolution of a stalked, intrinsic brush border protein |
Q39470753 | The use of recombinant DNA techniques for the diagnosis of familial hypercholesterolaemia |
Q35180870 | The very low density lipoprotein (VLDL) receptor--a peripheral lipoprotein receptor for remnant lipoproteins into fatty acid active tissues. |
Q83230328 | The very low density lipoprotein receptor A second lipoprotein receptor that may mediate uptake of fatty acids into muscle and fat cells |
Q28281141 | The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor |
Q40665444 | The yeast Vps10p cytoplasmic tail mediates lysosomal sorting in mammalian cells and interacts with human GGAs. |
Q24595190 | The yeast alpha-factor receptor: structural properties deduced from the sequence of the STE2 gene |
Q40767999 | Therapeutic strategies for familial hypercholesterolemia based on somatic gene transfer. |
Q70821098 | Three novel mutations in the EGF precursor homology domain of the low-density lipoprotein receptor gene in Northern Irish patients with familial hypercholesterolemia |
Q41270687 | Three novel partial deletions of the low-density lipoprotein (LDL) receptor gene in familial hypercholesterolemia |
Q78048676 | Three novel small deletion mutations of the LDL receptor gene in Korean patients with familial hypercholesterolemia |
Q33861421 | Three pools of plasma membrane cholesterol and their relation to cholesterol homeostasis |
Q44151760 | Tissue- and stage-specific expression of two lipophorin receptor variants with seven and eight ligand-binding repeats in the adult mosquito |
Q36223333 | Tissue-specific sorting of the human LDL receptor in polarized epithelia of transgenic mice |
Q30357983 | Topological mapping of complement component C9 by recombinant DNA techniques suggests a novel mechanism for its insertion into target membranes. |
Q47921201 | Topology of SREBP cleavage-activating protein, a polytopic membrane protein with a sterol-sensing domain |
Q34300484 | Transcript encoded on the opposite strand of the human steroid 21-hydroxylase/complement component C4 gene locus |
Q35798254 | Transcription and translation of gp600 and receptor-associated protein (RAP) in active Heymann nephritis. |
Q34424419 | Transcription of human endogenous retroviral long terminal repeat (LTR) sequence in a lung cancer cell line. |
Q28278204 | Transcriptional regulation of squalene epoxidase by sterols and inhibitors in HeLa cells |
Q44834985 | Transferrin receptor internalization sequence YXRF implicates a tight turn as the structural recognition motif for endocytosis |
Q39764964 | Transforming growth factors and control of neoplastic cell growth |
Q41091365 | Transmembrane orientation and receptor-like structure of the Rhizobium meliloti common nodulation protein NodC. |
Q34293503 | Transmembrane signaling by a chimera of the Escherichia coli aspartate receptor and the human insulin receptor |
Q102219374 | Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies |
Q58577320 | Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA |
Q48143728 | Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity. |
Q35814601 | Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners |
Q34308576 | Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects |
Q73324760 | Two mutations in the same low-density lipoprotein receptor allele act in synergy to reduce receptor function in heterozygous familial hypercholesterolemia |
Q72223150 | Two new polymorphisms in the coding sequence of the LDL receptor (LDLR) gene |
Q72567837 | Two novel frameshift mutations associated with the presence of direct repeats of the LDL receptor gene in familial hypercholesterolemia |
Q46868847 | Two novel frameshift mutations in the low density lipoprotein receptor gene generated by endogenous sequence-directed mechanisms |
Q77795840 | Two novel low-density lipoprotein receptor gene mutations (E397X and 347delGCC) in St. Petersburg familial hypercholesterolemia |
Q44066590 | Two novel mutations in the LDL receptor gene: common causes of familial hypercholesterolemia in a Spanish population. |
Q46757320 | Two novel point mutations causing receptor-negative familial hypercholesterolemia in a South African Indian homozygote. |
Q74431145 | Two novel slavic point mutations in the low-density lipoprotein receptor gene in patients with familial hypercholesterolemia from St. Petersburg, Russia |
Q28286890 | Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene |
Q47372629 | UbiA prenyltransferase domain-containing protein-1 modulates HMG-CoA reductase degradation to coordinate synthesis of sterol and nonsterol isoprenoids |
Q40565715 | Ubiquitination of 3-hydroxy-3-methylglutaryl-CoA reductase in permeabilized cells mediated by cytosolic E1 and a putative membrane-bound ubiquitin ligase. |
Q48346921 | Unequal crossing-over between two alu-repetitive DNA sequences in the low-density-lipoprotein-receptor gene. A possible mechanism for the defect in a patient with familial hypercholesterolaemia |
Q48039508 | Unique expression pattern of a novel mosaic receptor in the developing cerebral cortex |
Q35434524 | Universal primer quantitative fluorescent multiplex (UPQFM) PCR: a method to detect major and minor rearrangements of the low density lipoprotein receptor gene |
Q36215085 | Unusual forms of low density lipoprotein receptors in hamster cell mutants with defects in the receptor structural gene |
Q46715028 | Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database |
Q81811677 | Update of Japanese common LDLR gene mutations and their phenotypes: Mild type mutation L547V might predominate in the Japanese population |
Q46775373 | Update of the molecular basis of familial hypercholesterolemia in The Netherlands |
Q73965800 | Upregulation of low density lipoprotein receptor by gemfibrozil, a hypolipidemic agent, in human hepatoma cells through stabilization of mRNA transcripts |
Q54718361 | Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100 |
Q35598612 | Use of hydrophobicity profiles to predict receptor binding domains on apolipoprotein E and the low density lipoprotein apolipoprotein B-E receptor |
Q36967619 | Use of mutant 125I-perfringolysin O to probe transport and organization of cholesterol in membranes of animal cells |
Q53805186 | Use of the single-strand conformational polymorphism method to detect recurrent and novel mutations in the low-density lipoprotein receptor gene in patients with familial hypercholesterolaemia: detection of a novel mutation Asp200-->Gly. |
Q41533261 | VLDL receptor in health and disease: interview with a receptor in avian oocytes and mammalian muscle and fat cells |
Q35874716 | Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms |
Q41429335 | Very low density lipoprotein receptor from mammary gland and mammary epithelial cell lines binds and mediates endocytosis of M(r) 40,000 receptor associated protein |
Q38331452 | Very-low-density lipoprotein receptor fragment shed from HeLa cells inhibits human rhinovirus infection |
Q73977888 | Vesicle-reconstituted low density lipoprotein receptor. Visualization by cryoelectron microscopy |
Q37951273 | Why are proteins O-glycosylated? |
Q46738759 | Worldwide genetic variation at the 3'-UTR region of the LDLR gene: possible influence of natural selection |
Q35980734 | Zipper encodes a putative integral membrane protein required for normal axon patterning during Drosophila neurogenesis |
Q28276544 | cDNA and Gene Structure for a Human Subtilisin-Like Protease with Cleavage Specificity for Paired Basic Amino Acid Residues |
Q35020483 | cDNA clones encoding bovine interphotoreceptor retinoid binding protein |
Q24321492 | cDNA cloning of a new low-density lipoprotein receptor-related protein and mapping of its gene (LRP3) to chromosome bands 19q12-q13. 2 |
Q28119181 | cDNA cloning, sequencing and chromosomal assignment of the gene for mouse complement factor I (C3b/C4b inactivator): identification of a species specific divergent segment in factor I |
Q24621040 | cDNA sequences of two inducible T-cell genes |
Q41016118 | fur gene expression as a discriminating marker for small cell and nonsmall cell lung carcinomas |
Q45232187 | sevenless: Seven found? |
Q34167835 | slit: an EGF-homologous locus of D. melanogaster involved in the development of the embryonic central nervous system |
Q58474059 | β-Sheet secondary structure of an LDL receptor domain from complement factor I by consensus structure predictions and spectroscopy |
Q54970925 | SV-589 | described by source | P1343 |
Search more.